The Pharmaceutical Care Management Association (PCMA) retained PricewaterhouseCoopers (PwC) to estimate the value of pharmacy benefit management as well as the potential impact of enactment of proposed legislation that would restrict pharmacy benefit management (PBM) activities for consumers, private employers, health plans, unions, and state and federal governments.
This report provided an objective analysis of the savings achieved by PBMs and organizations that provide PBM functions. These savings could be at risk, depending on the outcome of various legislative proposals.
Knowing the savings achieved through various pharmacy benefit methods, policymakers can make better decisions about the outcomes of such legislative porposals.
Republished with permission from the Pharmaceutical Care Management Association (PCMA), 2007.
Publications Search Page